在抗病毒药物开发当前的景观,对简单疹病毒感染的抗病毒药物
Fanny Frejborg1,2, Kiira Kalke2, Veijo Hukkanen2
1Pharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
Smart medicine
|August 27, 2024
概括
对简单疹病毒 (HSV) 迫切需要新型抗病毒疗法,因为目前的治疗方法无法消除病毒泄漏,并且正在出现耐药菌株. 本综述探讨了包括基因编辑和生物制药在内的有希望的新方法,用于治疗HSV感染和消除潜伏.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 简单疹病毒 (HSV) 影响全球90%的成年人,导致口腔面部和生殖器损伤,脑炎和失明.
- HSV 建立了终身潜伏状态,并逃避免疫反应,使治疗和预防工作复杂化.
- 目前的核酸模拟治疗方法不足,导致病毒分泌,传播和耐药菌株的出现.
研究的目的:
- 对简单疹病毒 (HSV) 的当前和新兴抗病毒疗法进行审查.
- 突出管理HSV感染和根除潜伏病毒的新策略.
- 解决尚未满足的医疗需求,有效的HSV治疗,由世卫组织认可.
主要方法:
- 目前关于HSV抗病毒疗法的文献综述.
- 讨论小分子抑制剂,生物制药和天然产品.
- 探索基因编辑和基于寡核酸的治疗方法.
主要成果:
- 目前对HSV感染的现有治疗方法无法完全防止病毒的分泌或传播.
- 耐药性HSV菌株对当前的治疗方案构成重大挑战.
- 新兴疗法显示出提高潜伏性HSV的疗效和根除潜伏性HSV的潜力.
结论:
- 由于治疗的局限性和耐药性,对抗HSV的新型抗病毒治疗非常需要.
- 基因编辑和生物制药等创新方法为未来的HSV治疗提供了有希望的途径.
- 对这些新策略的进一步研究对于应对全球 HSV 感染和潜伏的负担至关重要.
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K


